In May 2016, letters were sent regarding Nexplanon (etonogestrel implant) and ERWINASE.
In May 2016, letters were sent regarding:
Nexplanon (etonogestrel) implants have been found rarely in the vasculature and lung: an update regarding possible risks and complications regarding insertion, localisation and removal (Nexplanon letter to healthcare professionals May 2016)—see also article in this issue
ERWINASE: notice of special handling instructions—vials of ERWINASE from batch 174g should be used with a 5-micron filter needle (ERWINASE letter to healthcare professionals May 2016)
Article citation: Drug Safety Update vol 9 issue 11, June 2016: 4.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.